Zobrazeno 1 - 10
of 24
pro vyhledávání: '"M, Desnos"'
Autor:
E. Tavernier, M Desnos-Ollivier, Karine Augeul-Meunier, D. Guyotat, Jérôme Cornillon, Micha Srour, Amandine Fayard, F Honeyman, H. Raberin
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2015, 50 (1), pp.158-160. ⟨10.1038/bmt.2014.230⟩
Bone Marrow Transplantation, 2015, 50 (1), pp.158-160. ⟨10.1038/bmt.2014.230⟩
Bone Marrow Transplantation, Nature Publishing Group, 2015, 50 (1), pp.158-160. ⟨10.1038/bmt.2014.230⟩
Bone Marrow Transplantation, 2015, 50 (1), pp.158-160. ⟨10.1038/bmt.2014.230⟩
Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f29d91b1665ba7c66b6a3c353093f6
https://hal-pasteur.archives-ouvertes.fr/pasteur-02194803
https://hal-pasteur.archives-ouvertes.fr/pasteur-02194803
Autor:
P, Charron, D, Héron, M, Gargiulo, P, Richard, O, Dubourg, M, Desnos, J B, Bouhour, J, Feingold, L, Carrier, B, Hainque, K, Schwartz, M, Komajda
Publikováno v:
Journal of Medical Genetics. 39:741-746
A major breakthrough in the molecular genetics of hypertrophic cardiomyopathy (HCM) has made genetic testing now available in clinical practice, raising new questions about its implications, potential benefits, and the organisation of the procedure.
Autor:
X, Jouven, A, Hagege, P, Charron, L, Carrier, O, Dubourg, J M, Langlard, S, Aliaga, J B, Bouhour, K, Schwartz, M, Desnos, M, Komajda
Publikováno v:
Heart. 88:153-157
Background: QT abnormalities have been reported in left ventricular hypertrophy and hypertrophic cardiomyopathy. Objective: To determine the relation between left ventricular hypertrophy and increased QT interval in familial hypertrophic cardiomyopat
Autor:
E, Hery, P, Jourdain, F, Funck, M, Bellorini, J, Loiret, B, Thebault, N, Guillard, A, El Hallak, M, Desnos
Publikováno v:
Annales de cardiologie et d'angeiologie. 53(6)
Beta-blocker therapy is actually recommended as first line therapy for systolic heart failure. However, beta-blocker have a low prescription rate comparatively to ACEI. Beta-blocker potential side effects as bradycardia, hypotension and especially ac
Publikováno v:
Annales de cardiologie et d'angeiologie. 52(5)
Natriuretic Peptides like BNP or NT Pro BNP are diagnostic and prognostic makers largely used in clinical practice. Ageing may increase these peptides, especially in case of comorbidities like renal failure or hypertension and require adjustment for
Autor:
P, Jourdain, F, Funck, M, Bellorini, S, Neau, H, Mat, N, Abdelmoumene, C, Pege, A, Piccini, A, Astred, B, Thebault, J, Loiret, N, Guillard, M, Desnos
Publikováno v:
Annales de cardiologie et d'angeiologie. 52(5)
Prognosis for heart failure is linked to patient's compliance. Compliance is also dependent from patient education about his disease and treatment. Therapeutic education could be done in a community hospital but needs a lot of time. However, therapeu
Autor:
P, Jourdain, F, Funck, M, Bellorini, C, Josset, C, Piednoir, N, Pons, J, Loiret, N, Guillard, B, Thebault, M, Desnos
Publikováno v:
Annales de cardiologie et d'angeiologie. 51(5)
Chronic heart failure is linked to high rate of death and hospitalization. Some studies have highlighted the beneficial effect of heart failure clinics on morbidity and mortality. We have developed this type of structure at CHR Dubos since 3 years an
Publikováno v:
European heart journal. 21(9)
Rationale The epidemiology of heart failure and patient management procedures may vary from one country to another. This study was designed to analyse the spectrum of patients hospitalized in France for heart failure. Patients and Methods A registry
Autor:
L, Tiret, C, Mallet, O, Poirier, V, Nicaud, A, Millaire, J B, Bouhour, G, Roizès, M, Desnos, R, Dorent, K, Schwartz, F, Cambien, M, Komajda
Publikováno v:
Journal of the American College of Cardiology. 35(1)
The study investigated the potential role of eight candidate genes in the susceptibility to idiopathic dilated cardiomyopathy (IDC).Idiopathic dilated cardiomyopathy has a familial origin in 20% to 25% of cases, and several genetic loci have been ide
Autor:
P, Gibelin, M C, Aumont, J F, Aupetit, P, Bareiss, J B, Bouhour, M, Desnos, O, Dubourg, A, Hagège, G, Jondeau, M, Komajda
Publikováno v:
Archives des maladies du coeur et des vaisseaux. 92(9)
Many systems have been proposed to evaluate the functional incapacity caused by chronic cardiac failure. The classification of the New York Heart Association (NYHA) is the best known. It is subjective, poorly reproducible and has a poor predictive va